Michael glickman biography
Home / General Biography Information / Michael glickman biography
He completed Infectious Diseases clinical training at the Albert Einstein College of Medicine/Montefiore Medical Center. He advanced his career with various roles at the Center before becoming its Chief Operating Officer in 2007.
He loves the fact that he can connect to his culture side and connect the arts to the community. He has been Visiting Scientist/Visiting Professor in the U.S.A. During his tenure, he spearheaded fundraising of $100 million in philanthropic support from both public and private sectors, and grew the Center for Jewish History into a premier cultural destination for visitors and scholars around the world.
After working in the Center for over a decade, Glickman returned to LIU in 2014 as a Vice- President, serving as Chief of Strategic Partnerships and University Advancement.
Mike Glickman, M.D.
Scientific Advisory Board
Scientific Advisor
Michael S. Glickman MD is a Member in the Immunology Program of the Sloan Kettering Institute, an Attending Physician in Infectious Diseases at Memorial Hospital, and an Alfred Sloan Chair at MSKCC.
In 1999 he became Senior Lecturer (assistant Professor) at the Technion – Institute of Technology in Haifa, Israel, where he has been full professor since 2009. Aside from the very demanding job and family life, he hopes to find time to play golf, read at his leisure, and take advantage of the many wonders New York City.
Back to Blog HomepageThe Israel Isaac and Natalia Kudish Academic Chair,
Room No.
438,
Faculty of Biology, Technion – Israel Institute of Technology, Haifa-32000. Michael Glickman was born in Uppsala, Sweden in 1964 and lives now in Haifa with his family.
.
at the National Cancer Institute (NCI) in Bethesda, Maryland and at the University of Maryland as well as in France at the Institute Jacques Monod and the University Paris Diderot in Paris.He is also an expert in the mechanisms of action of BCG as a cancer therapy, in addition to the intersection of cancer cells with microbes. Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements.
In this role Michael was an advisor to the President and directly oversaw fundraising, alumni relations, government and community affairs, strategy and planning, policy & analysis, LIU’s partnership with START-UP NY, and more, across the various campuses of the university.
Michael Glickman was appointed President & CEO of The Museum of Jewish Heritage (MJH) in September 2016.
“This is an institution that has its doors wide open and I’m hopeful that our neighbors in the community will take advantage of what we have to offer.”
Michael lives in Long Island with his wife and three children. From there he went to Harvard Medical School in Boston. With the award, Professor Glickman will intensify his long-standing collaboration with the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch.
While working at the Center, Michael attended Columbia University and received a Master of Public Administration degree with a concentration in management and finance. Born and Raised in New Hyde Park on Long Island, Michael received his Bachelors and Masters degrees in Political Science from Long Island University (LIU).
Dr. Glickman is a graduate of Dartmouth College, where he studied literature, focusing on poetry of the British Romantic Period. A microbiologist and immunologist, Dr. Glickman’s research focuses of the pathogenesis of mycobacterial infections and the interaction of microbes with cancer cells. Dr. Glickman is an AOA graduate of Columbia University College of Physicians and Surgeons and completed internal medicine clinical training at the Massachusetts General Hospital of Harvard Medical School.
He was a postdoctoral fellow with Dr. William Jacobs of AECOM and HHMI. Dr. Glickman has discovered and characterized multiple pathways in both pathogen and host that mediate mycobacterial infection.